Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:MDVL

MedAvail (MDVL) Stock Price, News & Analysis

MedAvail logo

About MedAvail Stock (NASDAQ:MDVL)

Key Stats

Today's Range
N/A
50-Day Range
$1.80
$5.95
52-Week Range
N/A
Volume
245,100 shs
Average Volume
261,432 shs
Market Capitalization
$2.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

Delhi Bank Corp DWNX
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
See More Headlines

MDVL Stock Analysis - Frequently Asked Questions

MedAvail Holdings, Inc. (NASDAQ:MDVL) released its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.02. The firm had revenue of $5.79 million for the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MedAvail investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Braze (BRZE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/08/2021
Today
11/22/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Current Symbol
NASDAQ:MDVL
Employees
279
Year Founded
N/A

Profitability

Net Income
$-47,620,000.00
Net Margins
-192.97%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.33 million
Book Value
$13.01 per share

Miscellaneous

Free Float
1,590,000
Market Cap
$2.91 million
Optionable
No Data
Beta
0.76
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

This page (NASDAQ:MDVL) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners